MarketPeel
Insider Trading Intelligence
MD

Marc Duey

APRE
DIRECTOR · APREA THERAPEUTICS, INC. · CIK 0001925150
FILING MIX · LIFETIME84%/16%
BUYS
16
SELLS
3
TOTAL VALUE
$186.8K
COMPANIES
1
ACTIVE SINCE
Jul 2022
HOLDINGS NOW
12,555
AVG SELL PX
$4.58
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 7 pending
Forward-return performance of every backtestable P/S trade by Marc Duey, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%+14.34%-1.30%+15.64%+2.13%
14d5+100.00%+15.88%-0.50%+16.38%+3.87%
30d5+80.00%-0.66%+1.06%-1.72%+2.67%
60d5+40.00%-12.28%+2.57%-14.85%-27.46%
90d5+60.00%+0.88%-0.27%+1.14%-7.37%
180d5+20.00%-39.36%-1.97%-37.38%-31.41%
1y5(2 pending)+33.33%-53.78%+14.20%-67.98%-70.18%
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
APRE · 12,555 shares · as of Jun 16, 2026
01,041,8972,083,7953,125,6924,167,5892023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 3 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,55512,555Jun 16, 2026Jun 17, 2026View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,135259,290Jun 16, 2026Jun 17, 2026View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
21,459$1.17$25.0K256,155Dec 10, 2025Dec 11, 2025View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
21,45921,459Dec 10, 2025Dec 11, 2025View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,045234,696Jun 5, 2025Jun 9, 2025View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,1854,185Jun 5, 2025Jun 9, 2025View →
APRE
APREA THERAPEUTICS, INC.
SALE
6,462$4.58$29.6K233,651Oct 18, 2024Oct 25, 2024View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
30,000$4.39$131.7K240,113Oct 16, 2024Oct 17, 2024View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
190$2.58$490210,113Oct 14, 2024Oct 16, 2024View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,1854,185Jun 20, 2024Jun 21, 2024View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,045209,923Jun 20, 2024Jun 21, 2024View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,0002,000Aug 23, 2023Aug 24, 2023View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
500208,878Aug 23, 2023Aug 24, 2023View →
APRE
APREA THERAPEUTICS, INC.
SALE
400,9690Aug 23, 2022Aug 24, 2023View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
11,610602Aug 23, 2022Aug 24, 2023View →
APRE
APREA THERAPEUTICS, INC.
SALE
1,1610Aug 23, 2022Aug 24, 2023View →
APRE
APREA THERAPEUTICS, INC.
PURCHASE
4,009,6904,167,589Aug 23, 2022Aug 24, 2023View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,995157,899Jul 28, 2022Aug 1, 2022View →
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
29,57529,575Jul 28, 2022Aug 1, 2022View →
Other insiders · APRE
Loading peer insiders…
About this filer
CIK 0001925150
ROLE
Director
PRIMARY
APRE
COMPANIES
1
ACTIVE SINCE
Jul 2022
MARKETPEEL · /INSIDER/0001925150DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback